Verified Mercor opportunity
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales. — Responsibilities • Create and critique rubrics that analyze commercial drugs and drug-development programs • Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions • Apply your assessment across the pilot's set of companies (~5–10) — Requirements • US-based biotech / healthcare investment analyst with a specialist-fund background • Familiarity with biotech/pharma development programs • Able to assess a drug asset and the company behind it end-to-end • 5+ years evaluating biotech/pharma companies or assets — Engagement Details • Duration: Approximately 10–20 hours over a 1–2 week pilot • Remote — US-based — Why Participate • Help improve expert AI evaluation of drugs and drug-development programs • Recurring engagement for strong contributors